Sacubitril/valsartan verdient geen voorkeur boven ACE-remmer na een hartinfarct

Publikováno v: Nederlands tijdschrift voor geneeskunde. 166

The PARADISE-MI study compared standard treatment with an ACE inhibitor (ramipril) after an acute myocardial infarction with the newer sacubitril/ valsartan combination (so-called ARNI) medication in 5661 patients. Most patients had a reduced cardiac

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dris___00893::3c19389907a7e8ae1d13e42a2a150343

Effects of ACE inhibitors and angiotensin receptor blockers: protocol for a UK cohort study using routinely collected electronic health records with validation against the ONTARGET trial

Autor: Paris J Baptiste, Angel Y S Wong, Anna Schultze, Marianne Cunnington, Johannes F E Mann, Catherine Clase, Clémence Leyrat, Laurie A Tomlinson, Kevin Wing

Publikováno v: Baptiste, P J, Wong, A Y S, Schultze, A, Cunnington, M, Mann, J F E, Clase, C, Leyrat, C, Tomlinson, L A & Wing, K 2022, ' Effects of ACE inhibitors and angiotensin receptor blockers : Protocol for a UK cohort study using routinely collected electronic health records with validation against the ONTARGET trial ', BMJ Open, vol. 12, no. 3, e051907 . https://doi.org/10.1136/bmjopen-2021-051907

IntroductionCardiovascular disease is a leading cause of death globally, responsible for nearly 18 million deaths worldwide in 2017. Medications to reduce the risk of cardiovascular events are prescribed based on evidence from clinical trials which e

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5f9155d32afd30d32c79d7e7fe86ea6
https://pubmed.ncbi.nlm.nih.gov/35260450

Sacubitril/Valsartan and Frailty in Patients With Heart Failure and Preserved Ejection Fraction

Autor: Jawad H. Butt, Pooja Dewan, Pardeep S. Jhund, Inder S. Anand, Dan Atar, Junbo Ge, Akshay S. Desai, Luis E. Echeverria, Lars Køber, Carolyn S.P. Lam, Aldo P. Maggioni, Felipe Martinez, Milton Packer, Jean L. Rouleau, David Sim, Dirk J. Van Veldhuisen, Bojan Vrtovec, Faiez Zannad, Michael R. Zile, Jianjian Gong, Martin P. Lefkowitz, Adel R. Rizkala, Scott D. Solomon, John J.V. McMurray

Publikováno v: Butt, J H, Dewan, P, Jhund, P S, Anand, I S, Atar, D, Ge, J, Desai, A S, Echeverria, L E, Køber, L, Lam, C S P, Maggioni, A P, Martinez, F, Packer, M, Rouleau, J L, Sim, D, Van Veldhuisen, D J, Vrtovec, B, Zannad, F, Zile, M R, Gong, J, Lefkowitz, M P, Rizkala, A R, Solomon, S D & McMurray, J J V 2022, ' Sacubitril/Valsartan and Frailty in Patients With Heart Failure and Preserved Ejection Fraction ', Journal of the American College of Cardiology, vol. 80, no. 12, pp. 1130-1143 . https://doi.org/10.1016/j.jacc.2022.06.037
Journal of the American College of Cardiology, 80(12), 1130-1143. ELSEVIER SCIENCE INC
Journal of the American College of Cardiology
Journal of the American College of Cardiology, 2022, 80 (12), pp.1130-1143. ⟨10.1016/j.jacc.2022.06.037⟩

BackgroundFrailty is an increasingly common problem, and frail patients are less likely to receive new pharmacologic therapies because the risk–benefit profile is perceived to be less favorable than in nonfrail patients.ObjectivesThis study investi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::597142429ac82f637f43ad6bf9250f5b
https://curis.ku.dk/portal/da/publications/sacubitrilvalsartan-and-frailty-in-patients-with-heart-failure-and-preserved-ejection-fraction(34894517-1613-415d-9f5a-e00c6f32c7cb).html

Temporal trends in heart failure medication prescription in a population-based cohort study

Autor: Harry Hemingway, Anoop D. Shah, Diederick E. Grobbee, Stefan Koudstaal, Ilonca Vaartjes, Alicia Uijl, Arno W. Hoes, Folkert W. Asselbergs, Spiros Denaxas, John G.F. Cleland

Publikováno v: BMJ Open, Vol 11, Iss 3 (2021)
BMJ Open
BMJ open, 11(3). BMJ Publishing Group

ObjectiveWe examined temporal heart failure (HF) prescription patterns in a large representative sample of real-world patients in the UK, using electronic health records (EHR).MethodsFrom primary and secondary care EHR, we identified 85 732 patients

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f78125800d507faaf36bd4e8fba6c59
https://bmjopen.bmj.com/content/11/3/e043290.full

Hypertension artérielle et cancer : une relation étroite à ne pas oublier [Hypertension and cancer : a close relationship to remember!]

Autor: Bocchi, F., Jankovic, J., Wuerzner, G.

Publikováno v: Revue medicale suisse, vol. 16, no. 706, pp. 1680-1683

Hypertension is a common clinical problem in patients with cancer. This is explained by its high prevalence in the general population, by the improvement in life expectancy in oncology patients thanks to the progress of anti-cancer therapies, but als

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______1900::fccbca1a879f5557430d0a8058186389
https://serval.unil.ch/notice/serval:BIB_287E2B1A62E4